STRUCTURAL BASIS FOR INHIBITION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR BY CETUXIMAB
No abstract prepared.
- Research Organization:
- Brookhaven National Lab. (BNL), Upton, NY (United States). National Synchrotron Light Source
- Sponsoring Organization:
- DOE/OFFICE OF SCIENCE
- DOE Contract Number:
- DE-AC02-98CH10886
- OSTI ID:
- 884406
- Report Number(s):
- BNL-76588-2005-JA; TRN: US0603623
- Journal Information:
- J. SYNCH. RAD., Vol. 12
- Country of Publication:
- United States
- Language:
- English
Similar Records
In Vitro Responsiveness of Glioma Cell Lines to Multimodality Treatment With Radiotherapy, Temozolomide, and Epidermal Growth Factor Receptor Inhibition With Cetuximab
STRUCTURAL BASIS BY WHICH ALTERNATIVE SPLICING CONFERS SPECIFICITY IN FIBROBLAST GROWTH FACTOR RECEPTORS
Inhibition of human tumor xenograft growth in nude mice by a conjugate of monoclonal antibody LA22 to epidermal growth factor receptor with anti-tumor antibiotics mitomycin C
Journal Article
·
Sun Jul 01 00:00:00 EDT 2007
· International Journal of Radiation Oncology, Biology and Physics
·
OSTI ID:884406
+3 more
STRUCTURAL BASIS BY WHICH ALTERNATIVE SPLICING CONFERS SPECIFICITY IN FIBROBLAST GROWTH FACTOR RECEPTORS
Journal Article
·
Wed Jan 01 00:00:00 EST 2003
· Proceedings of the National Academy of Sciences of the United States of America
·
OSTI ID:884406
+5 more
Inhibition of human tumor xenograft growth in nude mice by a conjugate of monoclonal antibody LA22 to epidermal growth factor receptor with anti-tumor antibiotics mitomycin C
Journal Article
·
Fri Oct 20 00:00:00 EDT 2006
· Biochemical and Biophysical Research Communications
·
OSTI ID:884406
+10 more